연구성과로 돌아가기

2023 연구성과별 연구자 정보 (828 / 2675)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study Do, Young Rok Do, YR 15 Keimyung Univ, Dept Hematooncol, Dongsan Med Ctr, Daegu, South Korea
Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study Park, Sungwoo Park, S 16 Gyeongsang Natl Univ Hosp, Dept Internal Med, Jinju Si, South Korea
Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study Lee, Junglim Lee, J 17 Daegu Fatima Hosp, Div Hematol Oncol, Ctr Canc, Daegu, South Korea
Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study Lee, Seung-Shin Lee, SS 18 Wonkwang Univ Hosp, Dept Hematol Oncol, Iksan, South Korea
Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study Kang, Hye Jin Kang, HJ 19 Korea Inst Radiol & Med Sci, Dept Internal Med, Div Hematol Oncol, Korea Canc Ctr Hosp, Seoul, South Korea
Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study Park, Young Hoon Park, YH 20 Ewha Womans Univ, Dept Internal Med, Coll Med, Seoul, South Korea
Efficacy and safety of carfilzomib, lenalidomide, and dexamethasone versus ixazomib, lenalidomide, and dexamethasone in real world patients with relapsed/refractory multiple myeloma: KMM2004 study Lim, Sung-Nam Lim, SN 21 Inje Univ, Coll Med, Haeundae Paik Hosp, Busan, South Korea
Efficacy and safety of CKD-495 in acute and chronic gastritis: A Phase III superiority clinical trial Seo, Seung Young Seo, SY 1 Jeonbuk Natl Univ, Dept Internal Med, Res Inst Clin Med, Biomed Res Inst,Jeonbuk Natl Univ Hosp, Jeonju, South Korea 0000-0003-2018-0013 Seo, seung young bear7905@jbnu.ac.kr;leeoy@hanyang.ac.kr;harley1333@hanmail.net;drchunhj@gmail.com;gasong@pusan.ac.kr;srjee@inje.ac.kr;parksj@ckdpharm.com;
Efficacy and safety of CKD-495 in acute and chronic gastritis: A Phase III superiority clinical trial Lee, Soo Teik Lee, ST 2 Jeonbuk Natl Univ, Dept Internal Med, Res Inst Clin Med, Biomed Res Inst,Jeonbuk Natl Univ Hosp, Jeonju, South Korea ABH-1408-2020 Lee, Si bear7905@jbnu.ac.kr;leeoy@hanyang.ac.kr;harley1333@hanmail.net;drchunhj@gmail.com;gasong@pusan.ac.kr;srjee@inje.ac.kr;parksj@ckdpharm.com;
Efficacy and safety of CKD-495 in acute and chronic gastritis: A Phase III superiority clinical trial Kim, Sung Kook Kim, SK 3 Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea D-2733-2015 Kim, Woo bear7905@jbnu.ac.kr;leeoy@hanyang.ac.kr;harley1333@hanmail.net;drchunhj@gmail.com;gasong@pusan.ac.kr;srjee@inje.ac.kr;parksj@ckdpharm.com;
Efficacy and safety of CKD-495 in acute and chronic gastritis: A Phase III superiority clinical trial Chun, Hoon Jai Chun, HJ 4 Korea Univ, Coll Med, Anam Hosp, Dept Internal Med, Seoul, South Korea bear7905@jbnu.ac.kr;leeoy@hanyang.ac.kr;harley1333@hanmail.net;drchunhj@gmail.com;gasong@pusan.ac.kr;srjee@inje.ac.kr;parksj@ckdpharm.com;
Efficacy and safety of CKD-495 in acute and chronic gastritis: A Phase III superiority clinical trial Song, Geun Am Song, GA 5 Pusan Natl Univ, Pusan Natl Univ Hosp, Sch Med, Dept Internal Med, Busan, South Korea bear7905@jbnu.ac.kr;leeoy@hanyang.ac.kr;harley1333@hanmail.net;drchunhj@gmail.com;gasong@pusan.ac.kr;srjee@inje.ac.kr;parksj@ckdpharm.com;
Efficacy and safety of CKD-495 in acute and chronic gastritis: A Phase III superiority clinical trial Lee, Dong Ho Lee, DH 6 Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seoungnam, South Korea J-5576-2012 Lee, Dong-Ho bear7905@jbnu.ac.kr;leeoy@hanyang.ac.kr;harley1333@hanmail.net;drchunhj@gmail.com;gasong@pusan.ac.kr;srjee@inje.ac.kr;parksj@ckdpharm.com;
Efficacy and safety of CKD-495 in acute and chronic gastritis: A Phase III superiority clinical trial Kim, Jae Jun Kim, JJ 7 Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea bear7905@jbnu.ac.kr;leeoy@hanyang.ac.kr;harley1333@hanmail.net;drchunhj@gmail.com;gasong@pusan.ac.kr;srjee@inje.ac.kr;parksj@ckdpharm.com;
Efficacy and safety of CKD-495 in acute and chronic gastritis: A Phase III superiority clinical trial Kim, Jin Il Kim, JI 8 Catholic Univ Korea, Yeouido St Marys Hosp, Coll Med, Dept Internal Med, Seoul, South Korea ACN-6827-2022 Kim, Min bear7905@jbnu.ac.kr;leeoy@hanyang.ac.kr;harley1333@hanmail.net;drchunhj@gmail.com;gasong@pusan.ac.kr;srjee@inje.ac.kr;parksj@ckdpharm.com;
페이지 이동: